loader from loading.io

S07 E02: VML’s Nichole Davies on the good, the bad and the ugly in women’s health

EMJ GOLD: Pharma marketing, medical & more

Release Date: 06/11/2024

Bonus episode: Pharma review of the year 2024 show art Bonus episode: Pharma review of the year 2024

EMJ GOLD: Pharma marketing, medical & more

As 2024 comes to a close, it's time to look back on a year in the pharmaceutical industry. In this final episode of the year, Isabel and Jade are joined by three former guest to reflect on the pivotal moments that defined the past 12 months. They are joined by Jennifer Schranz from Ipsen, Martina Dempsey from Astellas and Elias Revonta, CEO of Orcason, who all return to the podcast to share their insights. Together, they’ll discuss the major trends, challenges and breakthroughs that shaped 2024, including advancements in oncology, gene therapy, rare diseases and the growing role of AI. A...

info_outline
S08 E10: Bayer’s Dr Cecilia Caetano on making space for menopause show art S08 E10: Bayer’s Dr Cecilia Caetano on making space for menopause

EMJ GOLD: Pharma marketing, medical & more

In this final episode of the season, Isabel discusses how to normalise the conversation, not the suffering, around menopause with Dr Cecilia Caetano, Vice President, Head, Global Medical Affairs, Women’s Health, Bayer. Menopause affects over 50% of the world’s population, but its symptoms and effects are often misunderstood or ignored. Find out how industry can help by equipping not only HCPs but also women with the knowledge and awareness to manage menopause on an individual level, debunking the myths and prejudices surrounding the topic and much more.

info_outline
Season 8 highlights: GOLD Medal Moments show art Season 8 highlights: GOLD Medal Moments

EMJ GOLD: Pharma marketing, medical & more

Season 8 is almost over, but before we release our finale episode, why not take a listen to some of our favourite moments from the last couple of months? From an insight into why Gen Z might be turning their sails towards the pharmaceutical industry, to a call for a better understanding of HIV stigma, there’s plenty to discover in this season’s GOLD Medal Moments.

info_outline
S08 E09: World AMR Awareness Week with Orcason Medical’s Elias Revonta show art S08 E09: World AMR Awareness Week with Orcason Medical’s Elias Revonta

EMJ GOLD: Pharma marketing, medical & more

In this episode of the EMJ GOLD podcast, Jade and Isabel explore one of the most urgent global health issues: antimicrobial resistance (AMR). As part of World AMR Awareness Week, they are highlighting this year’s theme ‘Educate. Advocate. Act now’. Joining the conversation is Elias Revonta, Founder and CEO, Orcason Medical, who shares his vision for tackling AMR through groundbreaking medical technology. Orcason Medical is pioneering point-of-care devices for ear, nose and throat conditions to address the overprescription of antibiotics—a vital measure in the fight against AMR. A...

info_outline
S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK show art S08 E08: Alfasigma’s Patrick Oliver on the company’s new chapter in the UK

EMJ GOLD: Pharma marketing, medical & more

In this episode, Isabel welcomes Patrick Oliver, General Manager for the UK and Ireland at Alfasigma, to explore the company’s exciting entry into the UK market and the evolving landscape of healthcare in the country.   In the conversation, Patrick brings his wealth of industry experience to share his vision for Alfasigma’s future, the potential he sees in the UK healthcare market and the unique challenges ahead. They also delve into Lord Darzi’s report on the NHS, examining its implications for healthcare reform and innovation.  A little more on GOLD’s guest… ...

info_outline
S08 E07: What should marketing and medical affairs invest in for Q4? show art S08 E07: What should marketing and medical affairs invest in for Q4?

EMJ GOLD: Pharma marketing, medical & more

As 2024 draws to a close, what should pharma teams be focusing their budgets on for the final quarter of the year? Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024. As teams finalise their budgets and plan for the final quarter and year ahead, this conversation brings insights into how strategies like personalised engagement, thought leadership and interactive, on-demand content are making an impact. With real-life examples, learn about the tools you can invest in to end the year on a high.  

info_outline
S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women show art S08 E06: Ipsen’s Jennifer Schranz on rethinking rare disease for women

EMJ GOLD: Pharma marketing, medical & more

In this new episode, the team welcomes Jennifer Schranz, Senior Vice President, Global Head of Rare Diseases, Ipsen, to investigate the burden faced by women with rare diseases. Together, Jennifer and Jade discuss how the industry can address challenging rare diseases and making a meaningful impact on patients’ lives, the double jeopardy that women with rare diseases face, recent breakthroughs in the space and much more.

info_outline
S08 E05: ARS' Richard Lowenthal on his mission to transform allergy care show art S08 E05: ARS' Richard Lowenthal on his mission to transform allergy care

EMJ GOLD: Pharma marketing, medical & more

In the latest episode of our podcast, we welcome Richard Lowenthal, CEO, ARS Pharmaceuticals, to explore the company’s mission to address unmet needs in allergy care. During the conversation, Richard shares insights into his early career at the FDA and the regulatory challenges he faced in bringing ARS’s new nasal spray to treat severe allergic reactions to market. He also discusses the future direction of the company and much more. A little more on EMJ GOLD’s guest… Richard Lowenthal is the co-founder, President, and CEO, ARS Pharmaceuticals, with a leadership role since...

info_outline
S08 E04: Astellas’ Martina Dempsey on achieving equal footing for women in pharma show art S08 E04: Astellas’ Martina Dempsey on achieving equal footing for women in pharma

EMJ GOLD: Pharma marketing, medical & more

In the latest episode, Jade sits down with Martina Dempsey, Vice President of Commercial Strategy and Operations at Astellas Europe, to discuss empowering women in the pharmaceutical industry.  They explore how pharma meets the needs and values of young graduates, the ongoing challenges women face in securing leadership roles, the critical impact of mentorship on career development and much more. 

info_outline
S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic show art S08 E03: World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

EMJ GOLD: Pharma marketing, medical & more

In this episode, Isabel is joined by Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim, to mark World Mental Health Day on 10 October 2024.  Their conversation dives into the unique challenges faced by those living with serious mental illnesses, the impact of media representation and the role pharma can play in transforming treatment and quality of life for these patients.  Central to their discussion is the importance of amplifying lived experiences, a key focus of Boehringer’s new campaign, .  The campaign aims...

info_outline
 
More Episodes

With Season 7 in full swing, Isabel dives deep into the fascinating world of women’s health with Nichole Davies, Chief Strategy Officer, VML, to uncover the truth behind why women live longer but in poorer health and how the industry can incite change.

In the interview, they discuss the rise of FemTech, the challenge of funding and reimbursement, the role men can play in moving the conversation up the agenda and more.

A little more on GOLD’s guest…

Nichole leads the strategic disciplines and teams for the global VML Health network, overseeing research and development for all client and agency strategy and messaging. With over 20 years in the healthcare industry, she has worked in cities including London, New York, San Francisco, and Singapore. Nichole previously led strategy for Wunderman Thompson Health, Grey Health and Interbrand Health, following a decade in consulting.

Her experience covers diverse areas such as oncology, immunology, rare diseases, respiratory health, women's health, diabetes and nutrition. Nichole has collaborated with industry leaders like AstraZeneca, Pfizer and Johnson & Johnson.

Nichole graduated with honors in Chemistry from UMIST and completed her Postgrad in Marketing at London Business School. A Chartered Marketer, she is dedicated to driving change for improved patient outcomes and has worked with the Department of Health on patient communication standards.